Jefferies raises Jefferies Alnylam price target to $260
Jefferies raised its price target on Alnylam Pharmaceuticals to $260.00 per share from $230.00 and maintained a Hold rating,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.